Occupational and Environmental Medicine 2009;66:325-334
ORIGINAL ARTICLES
A panel study of air pollution in subjects with heart failure: negative results in treated patients
1 Department of Cardiology, Aberdeen Royal Infirmary, Aberdeen, UK
2 Institute of Occupational Medicine, Edinburgh, UK
3 Department of Environmental and Occupational Medicine, University of Aberdeen, Aberdeen, UK
4 Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
5 Department of Medicine and Therapeutics, University of Aberdeen, UK
Justin Barclay, Department of Cardiology, Aberdeen Royal Infirmary, Foresterhill, Aberdeen AB25 2ZP, UK; j.barclay{at}abdn.ac.uk
Objectives: To investigate preclinical adverse effects of ambient particulate air pollution and nitrogen oxides in patients with heart failure.
Methods: A cohort of 132 non-smoking patients living in Aberdeen, Scotland, with stable chronic heart failure were enrolled in a repeated-measures panel study. Patients with atrial fibrillation or pacemakers were excluded. Participants were studied for 3 days every 2 months for up to 1 year with monitoring of pollutant exposure and concurrent measurements of pathophysiological responses. Measurements included daily area concentration of particulate matter with a median aerodynamic diameter of <10 micrometres (PM10), particle number concentration (PNC) and nitrogen oxides; daily estimated personal concentration of particulate matter with a median aerodynamic diameter of <2.5 micrometres (PM2.5) and PNC exposures; and 3-day cumulative personal nitrogen dioxide (NO2). Concurrent meteorological data were recorded. Blood was taken at the end of each 3-day block for assays of markers of endothelial activation, inflammation and coagulation. Cardiac rhythm was monitored by ambulatory Holter monitor during the final 24 h of each block.
Results: The average 24 h background ambient PM10 ranged from 7.4 to 68 µg.m–3 and PNC from 454 to 11 283 particles.cm–3. No associations were demonstrated between the incidence of arrhythmias, heart rate variability or haematological/biochemical measures and any variations in pollutant exposures at any lags.
Conclusion: Assuming that low-level pollution affects the parameters measured, these findings may suggest a beneficial effect of modern cardioprotective therapy, which may modify responses to external risk factors. Widespread use of such drugs in susceptible populations may in future reduce the adverse effects of air pollution on the heart.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Full Text (PDF)
-
All Versions of this Article:
oem.2008.039032v1
66/5/325 most recent - Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
- Citation Map
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
